Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics

Detalles Bibliográficos
Autores principales: Karamouzis, M V, Konstantinopoulos, P A, Papavassiliou, A G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359976/
https://www.ncbi.nlm.nih.gov/pubmed/17519904
http://dx.doi.org/10.1038/sj.bjc.6603807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359976/
https://www.ncbi.nlm.nih.gov/pubmed/17519904
http://dx.doi.org/10.1038/sj.bjc.6603807

Ejemplares similares